Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ciramadol. A new analgesic.

A D Cochrane, R Bell, J R Sullivan

    The Medical Journal of Australia
    |November 3, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Ciramadol effectively relieved mild to moderate pain at doses up to 60 mg. Higher doses did not achieve effective pain control in severe cases, with mild sedation and gastrointestinal issues as side effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Effects of dexmedetomidine on kidney and brain tissue microcirculation and histology in ovine cardiopulmonary bypass: a randomised controlled trial.

    Anaesthesia·2023
    Same author

    The Digestive Diverticula in the Carnivorous Nudibranch, <i>Melibe leonina</i>, Do Not Contain Photosynthetic Symbionts.

    Integrative organismal biology (Oxford, England)·2021
    Same author

    Renal haemodynamics and oxygenation during and after cardiac surgery and cardiopulmonary bypass.

    Acta physiologica (Oxford, England)·2017
    Same author

    Hearing AIDS and the brain.

    International journal of otolaryngology·2014
    Same author

    Influences of watershed characteristics on mercury levels in wisconsin rivers.

    Environmental science & technology·2011
    Same author

    Initiating allopurinol therapy: do we need to know the patient's human leucocyte antigen status?

    Internal medicine journal·2011

    Area of Science:

    • Pharmacology
    • Pain Management
    • Oncology

    Background:

    • Ciramadol (WY 15705) is a novel analgesic and narcotic antagonist.
    • Effective pain management is crucial, especially in patients with malignant diseases.

    Purpose of the Study:

    • To evaluate the analgesic dose and toxicity of oral Ciramadol.
    • To assess Ciramadol's efficacy in patients with varying pain levels, including those with cancer pain.

    Main Methods:

    • Oral administration of Ciramadol to 16 patients, primarily those with malignant disease.
    • Dose-ranging study to determine effective analgesic levels and observe adverse effects.

    Main Results:

    • Effective pain relief was achieved with 20-60 mg doses in patients with mild to moderate pain (mean 47 mg).

    Related Experiment Videos

  • Doses up to 82 mg did not provide effective pain control for moderate to severe pain.
  • Mild to moderate sedation (8 patients) and nausea/vomiting (2 patients) were observed side effects.
  • No consistent impact on vital signs (blood pressure, heart rate, respiratory rate) was noted.

    • Conclusions:

    • Ciramadol demonstrates analgesic potential for mild to moderate pain.
    • Higher doses may be required for severe pain, but efficacy is limited.
    • Toxicity profile includes sedation and gastrointestinal distress, necessitating careful dosing.